The role of protein acetylation in carcinogenesis and targeted drug discovery

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein acetylation is a vital post-translational modification regulating numerous cellular functions, including gene transcription and DNA repair.
• Aberrant protein acetylation is implicated in the pathogenesis and progression of various cancers.
• Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are key regulators of protein acetylation homeostasis.

Purpose of the Study:

• To review the multifaceted roles of protein acetylation in tumor pathology.
• To discuss therapeutic strategies targeting protein acetylation for cancer treatment.
• To highlight the implications of protein acetylation in understanding carcinogenesis and developing precision oncology treatments.

Main Methods:

• Literature review of studies on protein acetylation in cancer.
• Analysis of the regulatory mechanisms of HATs and HDACs in cancer.
• Examination of therapeutic agents targeting protein acetylation pathways.

Main Results:

• Protein acetylation influences critical cancer hallmarks, including malignant phenotypes and adaptation to the tumor microenvironment.
• Dysregulated acetylation levels are associated with cancer initiation and advancement.
• Targeting protein acetylation demonstrates potential as a viable therapeutic approach in oncology.

Conclusions:

• Protein acetylation is integral to cancer biology, influencing carcinogenesis and disease progression.
• Therapeutic interventions targeting protein acetylation pathways represent a promising avenue for cancer treatment.
• Understanding protein acetylation is foundational for advancing precision medicine in oncology.